Explore more publications!

Press Releases

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Coupang, Inc. of Class Action Lawsuit and Upcoming Deadlines - CPNG
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Smart Digital Group Limited of Class Action Lawsuit and Upcoming Deadlines - SDM
BRBR STOCK NEWS: BellRing Brands Stock Plummets and Additional 14% -- BFA Law Reminds Investors of its Pending Securities Fraud Class Action
Leslie’s, Inc. to Report First Quarter 2026 Financial Results on February 17, 2026
Telix Full Year Results 2025 Investor Webcast Notification
eGain Announces Second Quarter 2026 Financial Results
Enphase Energy Reports Financial Results for the Fourth Quarter of 2025
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
RADICL Secures $31M in Funding to Expand Its Autonomous Virtual SOC for SMBs Supporting U.S. Critical Infrastructure
InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025
Varonis Announces Fourth Quarter 2025 and Full-Year 2025 Financial Results
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA
Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target REalloys Inc. and AltynGroup Kazakhstan Sign Series of Agreements to Secure Kazakhstan Rare Earth Feedstock for U.S. Government Defense Stockpiles
Caring Brands Secures Two New U.S. Patents Strengthening Hair Enzyme Booster Technology
Myseum Granted and Issued U.S. Patent for Foundational Streaming and Content Sharing Technology
Vertex Report: U.S. Sees Record-Level Growth in Sales Tax Rates and Rules Changes in 2025 Amid Fiscal Uncertainty
VirTra to Demonstrate Next-Generation Drone Defense Marksmanship Training for Corrections at American Correctional Association Winter Conference
BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conference

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions